HALO

#910
Halozyme Therapeutics, Inc. - Common Stock
66.5 4 USD
-2.41%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
66.54
66.54
Year Range
0.68
82.22
Daily Change
-2.41%
Monthly Change
+5.27%
6 month change
-7.07%
Year Change
-0.39%
Previous Close
68.1 8
Open
66.5 4
Low
66.5 4
High
66.5 4
Volume
249
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

News